Results 351 to 360 of about 443,164 (406)

Mitochondrial-Mediated Platelet Activation in Polymyalgia Rheumatica. [PDF]

open access: yesACR Open Rheumatol
Michailidou D   +7 more
europepmc   +1 more source

Glucocorticoid Resistance Syndrome in 2 Patients With Diverse Genotype. [PDF]

open access: yesJCEM Case Rep
Battiola T   +3 more
europepmc   +1 more source

18F-FDG-PET/CT for polymyalgia rheumatica: agreement and diagnostic accuracy of routine PET scan report vs. standardized PMR PET scores. [PDF]

open access: yesFront Nucl Med
van der Geest KSM   +6 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Common myths of glucocorticoid function in ecology and conservation.

Journal of Experimental Zoology Part A Ecological and Integrative Physiology, 2021
Glucocorticoids are popular hormones to measure in both biomedical and ecological studies of stress. Many assumptions used to interpret glucocorticoid results are derived from biomedical data on humans or laboratory rodents, but these assumptions often ...
L. Romero, Ursula K Beattie
semanticscholar   +1 more source

Maternal care, hippocampal glucocorticoid receptors, and hypothalamic-pituitary-adrenal responses to stress.

Science, 1997
Variations in maternal care affect the development of individual differences in neuroendocrine responses to stress in rats. As adults, the offspring of mothers that exhibited more licking and grooming of pups during the first 10 days of life showed ...
Dong Liu   +9 more
semanticscholar   +1 more source

Glucocorticoid induced adrenal insufficiency

British medical journal, 2021
Synthetic glucocorticoids are widely used for their anti-inflammatory and immunosuppressive actions. A possible unwanted effect of glucocorticoid treatment is suppression of the hypothalamic-pituitary-adrenal axis, which can lead to adrenal insufficiency.
A. Prete, I. Bancos
semanticscholar   +1 more source

Glucocorticoids

Best Practice & Research Clinical Rheumatology, 2011
Glucocorticoids remain part of the treatment strategy in many rheumatic diseases, because of their anti-inflammatory and immunosuppressive actions. Unfortunately, their clinically desired effects are linked to adverse effects, especially at higher dosages and longer duration of treatment.
Cornelia M, Spies   +4 more
openaire   +2 more sources

Are Glucocorticoids DMARDs?

Annals of the New York Academy of Sciences, 2006
Abstract:  Disease modifying antirheumatic drugs (DMARDs) are drugs used in rheumatoid arthritis (RA) to control the disease and to limit joint damage and improve long‐term outcome. The last decade evidence has accumulated that suggests that low dosages of glucocorticoids are indeed able to control the disease and limit the destruction.
Bijlsma, Johannes W J   +4 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy